Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Programmed Death-ligand 1 (PD-L1)
100%
CD8+ T Cells
100%
Human Ovarian Cancer
100%
Tumor-infiltrating
100%
NY-ESO-1
100%
Tumor
44%
Peripheral Blood Lymphocytes
33%
Epithelial Ovarian Cancer
22%
Tumor-infiltrating Lymphocytes
22%
Tumor-associated Lymphocytes
22%
T Cells
11%
Humoral Immunity
11%
Therapeutic Targeting
11%
CD8+
11%
Effector Function
11%
T Cell Receptor
11%
Cytokine Production
11%
Ovarian Cancer Patients
11%
Immunogenic Tumor
11%
Antigen-presenting Cells
11%
Inhibitory Molecules
11%
T Cell Priming
11%
Interleukin-10
11%
Tumor Antigen
11%
Tolerance Mechanisms
11%
Antitumor Effect
11%
Cancer-testis Antigen
11%
Co-expression
11%
Inhibitory Receptors
11%
In Vitro Activation
11%
Ascites
11%
Dual Blockade
11%
IL-6 Cytokine
11%
Medicine and Dentistry
Neoplasm
100%
Cytotoxic T-Cell
100%
Ovarian Cancer
100%
Lymphocyte
71%
T Cell
28%
Krukenberg Tumor
28%
Tumor Infiltrating Lymphocyte
28%
Humoral Immunity
14%
Ex Vivo
14%
In Vitro
14%
Receptor
14%
CD8 Antigen
14%
Cytokine
14%
Tumor Necrosis Factor
14%
Interleukin 6
14%
Cytokine Production
14%
Tumor Antigen
14%
Tetramer
14%
Cancer Testis Antigen
14%
Interleukin 10
14%
Antigen Presenting Cell
14%
T Lymphocyte Receptor
14%
Ascites Tumor
14%
Immunology and Microbiology
Cytotoxic T-Cell
100%
Peripheral Blood Lymphocyte
42%
T Cell
28%
Tumor-Associated Macrophage
28%
Tumor-Infiltrating Lymphocytes
28%
Cytokine
14%
T Cell Receptor
14%
Interleukin 6
14%
Cytokine Production
14%
Humoral Immunity
14%
Antigen-Presenting Cell
14%
Tumor Antigen
14%
Tumor Necrosis Factor
14%
CD8
14%
Interleukin 10
14%
Cancer Testis Antigen
14%